Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where treatment method selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/pepe-coin-pepe-trader-names-the-next-big-gainer-for-2025/